1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Paul Kim: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allograft Dysfunction in Heart Transplant Regadenoson - Heart Transplant Failure and Rejection | Phase 4 | Recruiting | Paul Kim | 376 | 2019-10-01 | 2026-05-01 |
| Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction Regadenoson, Gadolinium, Cardiac MRI - Heart Transplant, Acute Graft Rejection | Phase 4 | Completed | Paul Kim | 14 | 2015-11-01 | 2017-08-22 |
regadenoson (2) · Gadolinium (1) · Gadolinium DTPA (1)
United States (2)
Paul J Kim, MD (1)
PMID 11693758, PMID 11943259, PMID 16890123, PMID 18551063, PMID 19284612, PMID 20413602, PMID 20643330, PMID 21555100, PMID 21962016, PMID 24355800, PMID 24457279, PMID 3308166